Mohammad Newaz MD, Ph.D., FAHA is a Professor of Physiology and Pharmacology and Chair of the Department of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). Before joining CSU Dr. Newaz was Associate Professor / senior Scientist and Head of Hypertension Unit in the Center for Cardiovascular Diseases, Texas Southern University, Houston, Texas. Dr. Newaz received his MD from University of Chittagong, Bangladesh (1992) and PhD from the National University of Malaysia (1998). He has held faculty positions at the University of Science and Technology Chittagong, Bangladesh, National University of Malaysia and International Islamic University Malaysia before joining the Center for Cardiovascular Diseases in 2000. His research focus is primarily on hypertension and vascular physiology using integrated investigative approach with special emphasis on understanding molecular events contributing to the pathogenesis of hypertension and its complications
Dr. Newaz is a member of many professional societies, including the American Heart Association, American Physiological Society. He has received numerous honors and awards, including the Young Investigator Award from High Blood Pressure Council of American Heart Association, Young Investigator Award from the renal section of The American Physiological Society, Caroline Tun Suden professional opportunity award from The American Physiological Society, Young Investigator Award from The International Society of Hypertension, FASEB MARC fellowship and Grant-in-Aid from American Heart Association. He has published more than 40 peer reviewed research paper in high impact journals, book chapters and invited reviews in the field of hypertension and vascular biology. Dr. Newaz presented his research works extensively at conferences locally and internationally and was also an invited speaker in several Universities in the US.
Ehab A. Abourashed, M.S., Ph.D., is an Associate Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP) and is a graduate of the Faculty of Pharmacy, Cairo University, Egypt. He has a Master's Degree in Organic Chemistry from the University of Tennessee, and a Ph.D. in Pharmacognosy from the University of Mississippi. Before joining CSU, Dr. Abourashed was a Lecturing Postdoctoral Research Associate at the University of Mississippi School of Pharmacy; a Senior Research Scientist at GlaxoSmithKline, New Jersey; Associate Professor of Pharmacognosy at King Saud University, Riyadh; and Director of Quality Assurance at ElSohly Labs, Inc. in Mississippi. Dr. Abourashed is also an Adjunct Research Associate Professor at the University of Mississippi’s National Center for Natural Products Research (NCNPR).
Dr. Abourashed's research interests include isolation, structure elucidation and microbial transformation of biologically active natural products; phyto/bioanalytical method development; and phytopharmacology of medicinal plants and herbal dietary supplements. Dr. Abourashed is currently investigating the psychopharmacology of nutmeg, the biological activities of milk thistle, and the antitubercular potentiating properties of selected natural phenolics and sesquiterpenes.
Dr. Abourashed is a member of the American Society of Pharmacognosy, The American Association of Colleges of Pharmacy, the Rho Chi Pharmacy Honor Society and the Phi Kappa Phi Honor Society. His name is also included in Who’s Who in the World 2006. Dr. Abourashed has published more than 30 research papers in peer reviewed journals and is a regular reviewer for the Journal of Natural Products, Planta Medica, Chromatographia and many others. He is also the coauthor of the 3rd edition of ‘Leung’s Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics’. Additional information at http://www.linkedin.com/in/abourashed.
Michael Danquah, M.S., Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He obtained his Bachelors in Chemical Engineering from Kwame Nkrumah University of Science and Technology, Ghana. Dr. Danquah has a Master’s Degree in Chemical Engineering from the University of Kentucky, and a Ph.D. in Pharmaceutics and Drug Delivery from the University of Tennessee Health Science Center.
Dr. Danquah’s research interests include: (i) Design and synthesis of novel biodegradable polymers for controlled drug and nucleic acid delivery, (ii) Nano based combination therapy for treating cancer, (iii) Design and construction of novel bipartite shRNA expressing plasmids for cancer therapy, (iv) Formulation, delivery, in vitro and in vivo characterization of siRNA and shRNA for treating cancer and (v) Application of stem cells and biomaterials for tissue regeneration and repair. His research accomplishments in these areas are documented in published peer-reviewed journal articles. Dr. Danquah also serves as a regular reviewer for Pharmaceutical Research and Advanced Drug Delivery Reviews and is a member of the American Association of Colleges of Pharmacy (AACP), the American Association of Pharmaceutical Scientists (AAPS), and the Controlled Release Society (CRS).
Jianjun Chen, B. Pharm., M.S., Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He obtained his B. Pharm from Shenyang Pharmaceutical University in China. Dr. Chen has a Master’s degree in Pharmaceutical Chemistry from Kangwon National University College of Pharmacy in S. Korea and a Ph.D. in Pharmaceutical Sciences from the University of Tennessee Health Science Center (UTHSC), College of Pharmacy. Prior to joining CSU-COP, he was an assistant professor of pharmaceutical sciences in South College School of Pharmacy.
Dr. Chen's research interests include: 1) drug discovery/medicinal chemistry: synthesis and biological testing of novel small molecules for the treatment of cancer; 2) bio-analytical chemistry: drug metabolism and structure elucidation of small molecules using high resolution NMR and mass spectrometry. Over the years, he has published more than 40 peer-reviewed papers in high impact journals in his field and is a regular reviewer for several professional and scientific journals. Dr. Chen is a co-inventor of multiple US and world patents. He has presented his research work at numerous national and international conferences and meetings such as AAPS, ACS, and AACR. Dr. Chen has also received awards in recognition of his research.
Duc P. Do, Ph.D., is an Associate Professor of Pharmaceutical Sciences (pharmaceutics) and Interim Associate Dean of Student Affairs at Chicago State University College of Pharmacy (CSU-COP). Prior to joining CSU-COP, he was an assistant professor of pharmaceutical sciences at Lake Erie College of Osteopathic Medicine (LECOM), School of Pharmacy. Dr. Do has received awards in recognition of his teaching, research and service.
Dr. Do received his B.S. from the University of Georgia and Ph.D. in pharmaceutical sciences (pharmaceutics) from Mercer University, College of Pharmacy & Health Sciences. His research interests are in the areas of cancer epigenetics, drug delivery systems, dosage form formulation, microencapsulation technology, and pharmaceutical compounding. Dr. Do has over 60 publications and presentations. Currently, he serves as a copyeditor for European Journal of Chemistry, as a member of the Editorial Board for seven (7) journals and as a reviewer for fourteen (14) scientific journals. Additionally, Dr. Do has served as an abstract and grant reviewer for several organizations.
In regards to teaching, he has taught pharmaceutics courses, including advanced drug delivery systems, pharmaceutical dosage forms, pharmaceutical compounding and pharmacokinetics.
Dr. Do is a member of several scientific and professional organizations, including the American Association of Colleges of Pharmacy (AACP) and the American Association of Pharmaceutical Scientists (AAPS).
Abir El-Alfy, B. Pharm., M.S., Ph.D., is an Associate Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP) and is a graduate of the Faculty of Pharmacy, Cairo University, Egypt. She has a Master's Degree in Microbiology from the University of Mississippi, and a Ph.D. in Pharmacology and Toxicology from the University of Mississippi. Before joining CSU, Dr. El-Alfy was an Assistant Professor of Pharmacology, as well as the Director of the Behavioral Neuroscience Core-NPN at the School of Pharmacy, University of Mississippi.
Dr. El-Alfy's research interest fall in two categories: 1) establishing the molecular mechanisms underlying the neurotoxicity of acrylamide in both young and adult animal models and 2) understanding the role of the endocannabinoid system in neuropsychiatric disorders as depression, anxiety, and posttraumatic disorder. The ultimate goal of his research is to develop novel drugs that prevent/treat the acrylamide-induced neurotoxicity as well as develop new therapeutic targets for the treatment of neuropsychiatric disorders.
Dr. El-Alfy has been teaching in Pharmacy Schools for over 10 years. Her teaching experiences span basic physiology and biochemistry to pharmacology and toxicity, clinical pharmacology and toxicology, as well as advance graduate courses.
Dr. El-Alfy's is a member of The American Association of Colleges of Pharmacy, The American Society of Pharmacology and Experimental Therapeutics, the American Society of Pharmacognosy, the Rho Chi Pharmacy Honor Society, and the Phi Kappa Phi Honor Society. Dr. El-Alfy has published more than 20 research papers in peer reviewed journals and is a regular reviewer for the Journal of Diabetes Complications, Planta Medica, Journal of Advanced Research, and many others. She holds two patents, one on developing indole compounds as antidepressant medication, and another on developing ptereostilbene as an anxiolytic. Dr. El-Alfy has presented her research extensively in regional, national, as well as international meetings. She has won several awads including a small NIH grant to examine the neurotoxic effects of acrylamide as well as an NIH COBRE junior investigator grant to examine the mechanism of antidepressant action of cannabinoids.
Nadeem Fazal, M.D, Ph.D. is a Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He received his MD from King Edward Medical University, Lahore, Pakistan, and PhD in Immunology from The University of Birmingham, England, United Kingdom. He is a member of American Association for Immunologists (AAI) and American Society for Microbiology (ASM). He completed his Post-doctoral training, Fellowship and later served as faculty at Stritch School of Medicine Loyola University Chicago. Dr. Fazal began his teaching career at the Department of Microbiology and Immunology, Rawalpindi Medical College, The University of Punjab, Lahore. He also served as faculty at Chicago State University Department of Biological Sciences. He has received President’s and Young Scientist Award from Societies of General Microbiology (SGM), American Society for Microbiology (ASM) and British Society for Immunology (BSI). He was also a recipient of Rowtham Bequest Award from The University of Birmingham, England, United Kingdom. His research interests include investigating mechanisms of cellular immune responses to acute injury/infection and pharmacological agents modulating such host responses. He has published more than 30 papers in peer-reviewed scientific journals. Dr. Fazal is a member of numerous scientific and professional organizations, including, The American Physiological Society (APS), The American Society of Human Genetics (ASHG), and The American Association of Colleges of Pharmacy (AACP).
Elmer J. Gentry, Ph.D., is a professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). Dr. Gentry received his B.S. from Missouri Western State College (1993 in Chemistry) and M.S. (1996) and Ph.D. (1999) in Medicinal Chemistry from the University of Kansas. He served on the faculty at Midwestern University, College of Pharmacy-Glendale from 1999-2007.
He was named the 2007 Teacher of the Year for both the first and second year pharmacy classes at the College of Pharmacy-Glendale. Additionally he has received the Edgar C. Little Outstanding Chemistry Graduate Award from Missouri Western State College, the Pharmacy Graduate Student Honors Symposium Award from the University of Kansas, and an American Foundation for Pharmaceutical Education Pre-doctoral fellowship from 1997-1999. He was honored as the National Advisor of the Year runner-up by the Phi Delta Chi pharmacy fraternity.
Dr. Gentry is a member of numerous scientific and professional organizations and has served as the Chair of the Section of Teachers of Chemistry of the American Association of Colleges of Pharmacy. His research interests include: synthetic manipulation of antimicrobial agents to modulate potency and spectrum of activity, use of combinatorial chemistry for drug discovery and development, and improving delivery of science courses for professional and pre-professional students.
Melany P. Puglisi, Ph.D. is an Associate Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). She received her B.A. in chemistry from Southampton College, now part of Long Island University, in 1991. Her graduate studies were carried out at University of Guam where she received her M.S. in Biology in 1995 and the University of Mississippi, School of Pharmacy where she received her Ph.D. in pharmacognosy. She received grants from the American Museum of Natural History and the Australian Museum of Natural History to conduct her research on Guam and the Great Barrier Reef (Lizard Island).
Prior to joining CSU she conducted post-doctoral research at Scripps Institution of Oceanography at the University of California at San Diego, the Smithsonian Marine Station at Fort Pierce, and Shannon Point Marine Station at Western Washington University. Dr. Puglisi’s research interests include marine natural products and chemical ecology of algae and marine invertebrates. She has participated in numerous research expeditions in the tropical Atlantic and Pacific including the 2005 NOAA Florida Coast Deep Corals research cruise.
Dr. Puglisi is a member of several scientific and professional organizations including the American Association of Colleges of Pharmacy (AACP) and the American Society of Pharmacognosy. She has served as chair of the Younger Members Committee of the ASP. Dr. Puglisi has received awards throughout her academic career that not only recognize her research achievements but also highlight her service to the community.
Mohammad Tauseef, M. Pharm., Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He completed his Pharmacy School from Faculty of Pharmacy, Jamia Hamdard (Hamdard University), New Delhi, India; and Ph.D., in Cardiovascular Pharmacology from Department of Pharmacology, Faculty of Medical Sciences, University of Delhi, India. Later, he joined Department of Pharmacology,
College of Medicine, The University of Illinois, Chicago, U.S., as a postdoctoral research associate. After completing his postdoctoral training in cardio-pulmonary pharmacology, he was appointed as a Research Assistant Professor in Department of Pharmacology, The University of Illinois, Chicago, IL.
Dr. Tauseef performs his biomedical research to investigate the role of calcium signaling in the regulation of vascular endothelial hyper-permeability and inflammation. Increase in endothelial permeability is the earliest sign in the initiation of serious cardio-pulmonary disorders during septic conditions, acute respiratory distress syndrome (ARDS) and diabetes mellitus. Dr. Tauseef is trying to identify molecular signaling mechanisms, activated during endothelial dysfunction to develop potential therapeutics against vascular inflammatory diseases. He utilizes array of techniques such as gene silencing technology in endothelial cells and genetic knockout mice models to answer his research questions. He regularly presents his research findings in various national and international scientific meetings such as Federations of America Society of Experimental Biology (FASEB), American Thoracic Society (ATS), American Heart Association (AHA), etc. He is recipient of several awards for his research presentations including Research Recognition Award from American Physiological Society (APS), Young Investigator Award by American Society for Pharmacology and Experimental Therapeutics (ASPET) and Gold Medal Prize, College of
Medicine (COM) Research, University of Illinois Chicago. He is an active member of American Association of College of Pharmacy (AACP), American Association of Immunologists (AAI), American Association of Pharmacology and Experimental Therapeutics. He is a member, Editorial Board, The Journal of Clinical Research. Dr. Tauseef has published his research work in top tier, peer reviewed international journals, such as Circulation Research, Journal of Experimental Medicine, The FASEB Journal. Dr. Tauseef is also an Adjunct Research Assistant Professor at the Center for and Vascular Biology, Department of Pharmacology, College of Medicine, The University of Illinois of Chicago, IL.
Bathsheba Ellis is an Administrative Aide in the Department of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). She has worked at CSU for 17 years in the College of Business. She has two sons and three beautiful grandchildren whom she adores spending time with. She also loves traveling, fine dining, and going to the theater. Her greatest joy comes from spending time at church, where she is active as a volunteer.
Daniel W. Pietryla is the Research Laboratory Technician Specialist for Chicago State University College of Pharmacy (CSU-COP). Mr. Pietryla received his Bachelors Degree in Biology from The University of Chicago (1983). Mr. Pietryla is the Lab Manager for the Pharmaceutical Sciences Research Facility.
Before joining the College of Pharmacy at CSU in 2012, Mr. Pietryla was a Research Assistant in the Departments of Biochemistry and Orthopedics at Rush University Medical Center in Chicago. In a career in basic research spanning 27 years, Mr. Pietryla has contributed to, as Co-Author, 6 major publications and 29 scientific abstracts in topics ranging from joint inflammation to intervertebral disc degradation and repair. Mr. Pietryla brings a diverse technical skills set in biochemical, histological, immunological, surgical, and clinical protocols and methodologies to the Pharmaceutical Sciences Research Lab. Additional information at http://www.linkedin.com/pub/dan-pietryla/39/4a8/331.